GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Altimmune Inc (STU:3G0) » Definitions » 5-Year Yield-on-Cost %

Altimmune (STU:3G0) 5-Year Yield-on-Cost % : 0.00 (As of Apr. 11, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Altimmune 5-Year Yield-on-Cost %?

Altimmune's yield on cost for the quarter that ended in Dec. 2024 was 0.00.


The historical rank and industry rank for Altimmune's 5-Year Yield-on-Cost % or its related term are showing as below:



STU:3G0's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.74
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Altimmune's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Altimmune's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Altimmune's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Altimmune's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Altimmune's 5-Year Yield-on-Cost % falls into.


;
;

Altimmune 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Altimmune is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Altimmune  (STU:3G0) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Altimmune 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Altimmune's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Altimmune Business Description

Traded in Other Exchanges
Address
910 Clopper Road, Suite 201S, Gaithersburg, MD, USA, 20878
Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Altimmune Headlines

No Headlines